<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01004055</url>
  </required_header>
  <id_info>
    <org_study_id>XSMP-011</org_study_id>
    <nct_id>NCT01004055</nct_id>
  </id_info>
  <brief_title>Efficacy Study of a Bioelectric Dressing to Treat Wounds Caused by Curettage and Electrodesiccation</brief_title>
  <official_title>Efficacy of the PROCELLERA Wound Dressing in the Healing of Wounds After Curettage and Electrodesiccation of Skin Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vomaris Innovations</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vomaris Innovations</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a bioelectric wound dressing, a
      silver-coated dressing, or a silver-foam dressing are effective in the treatment of wounds
      resulting from curettage and electrodesiccation of skin lesions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound healing over time</measure>
    <time_frame>July 2008-October 2009</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparing three FDA cleared products for pain reduction and incidence of infection</measure>
    <time_frame>July 2008-October 2009</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Wound Healing</condition>
  <condition>Wound Infection</condition>
  <arm_group>
    <arm_group_label>Procellera™ Wound Dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ACTICOAT™</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Mepilex® Ag</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Procellera™ Antimicrobial Wound Dressing</intervention_name>
    <description>Dressing indicated for partial and full-thickness wounds. Dressing changes every 2-3 days, more frequently if needed</description>
    <arm_group_label>Procellera™ Wound Dressing</arm_group_label>
    <other_name>PROCELLERA™, PROSIT™, Bioelectric Wound Dressing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ACTICOAT™ Antimicrobial Barrier Dressing</intervention_name>
    <description>Dressing changes every 2-3 days, more frequently if needed</description>
    <arm_group_label>ACTICOAT™</arm_group_label>
    <other_name>ACTICOAT™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mepilex® Ag Silver Foam Dressing</intervention_name>
    <description>Dressing changes every 2-3 days, more frequently if needed</description>
    <arm_group_label>Mepilex® Ag</arm_group_label>
    <other_name>Mepilex® Ag</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  If female, must either be not of childbearing potential or if they are of childbearing
             potential must have a negative urine pregnancy test

          -  Wound size greater than 1x1cm

          -  Wound must be ≥5 cm away from all other wounds

          -  Wound size must not be diminished in size greater than 10% between enrollment in study
             and the prescreening

          -  Participant agrees to participate in follow-up evaluation

          -  Participant must be able to read and understand informed consent, and sign the
             informed consent

        Exclusion Criteria:

          -  Concurrent participation in another clinical trial that involves an investigational
             drug or device that would interfere with this study

          -  Participant is to receive another topical antimicrobial agent other than the study
             dressing

          -  Participant with sensitivity or adverse reactions to silver or zinc

          -  Pregnancy or nursing an infant or child

          -  Immunosuppression

          -  Active or systemic infection

          -  Collagen vascular disease

          -  Diabetes

          -  Venous stasis ulcers

          -  Participant undergoing active cancer chemotherapy

          -  Chronic steroid use

          -  Decision impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott N Sheftel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheftel Associates Dermatology, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sheftel Associates Dermatology, LLC</name>
      <address>
        <city>Oro Valley</city>
        <state>Arizona</state>
        <zip>85755</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheftel Associates Dermatology, LLC</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2009</study_first_submitted>
  <study_first_submitted_qc>October 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2009</study_first_posted>
  <last_update_submitted>October 28, 2009</last_update_submitted>
  <last_update_submitted_qc>October 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Scott Sheftel, MD</name_title>
    <organization>Sheftel Associates Dermatology, LLC</organization>
  </responsible_party>
  <keyword>Wound</keyword>
  <keyword>Skin lesion</keyword>
  <keyword>Antimicrobial</keyword>
  <keyword>Bioelectric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 8, 2011</submitted>
    <returned>April 4, 2011</returned>
    <submitted>May 10, 2011</submitted>
    <returned>June 8, 2011</returned>
    <submitted>February 21, 2012</submitted>
    <returned>March 26, 2012</returned>
    <submitted>June 18, 2015</submitted>
    <returned>July 10, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

